Venture Map · Round
Tetraneuron — Other · €2.5M
Announced 2021-07-01 · Valencia · Biotech
Tetraneuron is developing a gene therapy for Alzheimer's disease. It raised more than €2.5M from unnamed investors specialised in biopharma and advanced therapies, with Borealis Corporate Finance advising; no stage was given.
RoundOther
Amount€2.5M
LeadNot disclosed
Date2021-07-01
CityValencia
SectorBiotech
The company
Investors
No investors were disclosed for this round.